0001753926-22-000348.txt : 20220328 0001753926-22-000348.hdr.sgml : 20220328 20220328151921 ACCESSION NUMBER: 0001753926-22-000348 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 EFFECTIVENESS DATE: 20220328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspargo Laboratories, Inc. CENTRAL INDEX KEY: 0001805092 IRS NUMBER: 843757833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-439247 FILM NUMBER: 22775188 BUSINESS ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 102 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: 201-408-4831 MAIL ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 102 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 D 1 primary_doc.xml X0708 D LIVE 0001805092 Aspargo Laboratories, Inc. 550 SYLVAN AVENUE, SUITE 102 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 201-408-4831 DELAWARE VirgaTech Inc. None Corporation true 2019 Michael Demurjian 610 Hubbard Avenue Red Bank NJ NEW JERSEY 07701 Executive Officer Director Promoter Michael Rice 155 Walnut Street Englewood NJ NEW JERSEY 07631 Director Fred Biehl 550 Sylvan Avenue, Suite 102 Englewood Cliffs NJ NEW JERSEY 07632 Director Pharmaceuticals No Revenues 06b false 2022-03-25 false true false 10000 Newbridge Securities Corporation 130814 None None 1200 NORTH FEDERAL HIGHWAY, SUITE 400 BOCA RATON FL FLORIDA 33432 FL FLORIDA MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS WA WASHINGTON false 60000000 1531998 58468002 false 19 91920 0 0 false Aspargo Laboratories, Inc. /s/ Michael Demurjian Michael Demurjian CEO 2022-03-28